
Amit Anand
Director, Translational Clinical Trials Program · Mass General Brigham
Credentials: · · ·
History
- Present
Translational Clinical Trials Program · Mass General Brigham
1993–1994
1992–1993- 1985–1989
Psychiatry
Research
Antidepressant effects of ketamine in depressed patients
Biological Psychiatry · 2000 · 3,030 citations
Biological Psychiatry · 2005 · First of 9 authors · Corresponding · 608 citations
Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments
Review · Molecular Psychiatry · 2002 · 422 citations
- MA
17 papers · 5 as a resident

16 papers

10 papers · 5 as a resident

9 papers

9 papers
- DO
8 papers
- FG
8 papers

8 papers · 1 as a fellow
Grants
- 2020–2026
National Institute of Mental Health · R01
PI · $2.5M · Cleveland Clinic Lerner Com-Cwru
- 2017–2025
National Institute of Mental Health · R01
Contact PI · $3.7M · Brigham and Women's Hospital
- 2011–2018
Differentiating Unipolar and Bipolar Depression in Young Adults Using fMRI
National Institute of Mental Health · R01
Contact PI · $2.3M · Cleveland Clinic Lerner Com-Cwru
- 2007–2012
Dysfunctional Cortico-Limbic Activity and Connectivity in Bipolar Disorder and Li
National Institute of Mental Health · R01
Contact PI · $1.8M · Indiana University Indianapolis
Clinical trials
- 2007–2012
FMRI Study of Brain Response Before and After Lithium Treatment in People With Bipolar Disorder
Principal investigator · Completed · Phase 4
Indiana University

